Keyuan Pharmaceutical announced that Linuo Pharmaceutical, a wholly-owned subsidiary, recently received drug registration certificates for engglicin metformin extended-release tablets and engagliptin metformin sustained-release tablets issued by the State Drug Administration. The approval numbers are Sinopharm Standard H20265843 and Sinopharm Standard H20265844, respectively.

Keyuan Pharmaceutical announced that Linuo Pharmaceutical, a wholly-owned subsidiary, recently received drug registration certificates for engglicin metformin extended-release tablets and engagliptin metformin sustained-release tablets issued by the State Drug Administration. The approval numbers are Sinopharm Standard H20265843 and Sinopharm Standard H20265844, respectively.